Replidyne
Replidyne officials announce the latest developments
Published in Lab Law Weekly, February 2nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Replidyne.
Report 1: Replidyne, Inc. (RDYN) announced that its executive director of Scientific Affairs, Glenn Tillotson, PhD, has been elected a fellow of the American College of Chest Physicians.
Tillotson is the only nonmedical doctor from industry to be inducted into the College.
Tillotson joined Replidyne in April 2006 with nearly 20 years comprehensive pharmaceutical experience, mainly in the field of anti-infectives. While with Bayer Pharmaceuticals,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-02-02)
More Articles from Lab Law Weekly
- Business Update
National Quality Care terminates merger and license agreements - Business Update
Report focuses on Lifescan Medical Device Company - Business Update
Research and Markets reports on Boston Scientific's merger with Guidant - Business Update
Spectranetics laser system used in neurovascular surgery for first time in U.S. - Cord Blood
Industry association offers perspective on cord blood banking - Generic Drugs
Savient launches authorized generic of oxandrolone tablets with Watson Pharmaceuticals - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
